Coffin-Lowry Syndrome

Overview

Journal Eur J Hum Genet

Specialty Genetics

Date 2009 Nov 6

PMID 19888300

Citations 50

Authors

Patricia Marques Pereira

Anne Schneider

Solange Pannetier

Delphine Heron

Andre Hanauer

Affiliations

Soon will be listed here.

Abstract

Coffin-Lowry syndrome (CLS) is a syndromic form of X-linked mental retardation, which is characterized in male patients by psychomotor and growth retardation and various skeletal anomalies. Typical facial changes and specific clinical and radiological signs in the hand are useful aids in the diagnosis. CLS is caused by mutations in the RPS6KA3 gene located at Xp22.2, which encodes RSK2, a growth-factor-regulated protein kinase. RPS6KA3 mutations are extremely heterogeneous and lead to loss of phosphotransferase activity in the RSK2 kinase, most often because of premature termination of translation.

Citing Articles

Airway management of a patient with coffin-lowry syndrome: a case report.

Ghose S, Nisar F, Aleem B BMC Anesthesiol. 2024; 24(1):291.

PMID: 39143512 PMC: 11323679. DOI: 10.1186/s12871-024-02667-7.

An unexpected presentation of very severe hypertriglyceridemia in a boy with Coffin-Lowry syndrome: a case report.

Tan S, Ahmad Narihan M, Koa A BMC Pediatr. 2023; 23(1):541.

PMID: 37898736 PMC: 10612235. DOI: 10.1186/s12887-023-04376-5.

Establishment of linkage phase, using Oxford Nanopore Technologies, for preimplantation genetic testing of Coffin-Lowry syndrome with a mutation.

Wen X, Du J, Li Z, Liu N, Huo J, Li J Front Genet. 2023; 14:1169868.

PMID: 37779904 PMC: 10538565. DOI: 10.3389/fgene.2023.1169868.

BörjesonForssmanLehmann syndrome: A case report.

Pan L, Yin F, Chen S, Xiong J, He F, Peng J Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2023; 48(2):294-301.

PMID: 36999477 PMC: 10930350. DOI: 10.11817/j.issn.1672-7347.2023.220414.

Activation and inhibition of the C-terminal kinase domain of p90 ribosomal S6 kinases.

Fruergaard M, Nielsen C, Kjeldsen C, Iversen L, Andersen J, Nissen P Life Sci Alliance. 2023; 6(5).

PMID: 36806093 PMC: 9941302. DOI: 10.26508/lsa.202201425.

References

Thomas G, Rumbaugh G, Harrar D, Huganir R . Ribosomal S6 kinase 2 interacts with and phosphorylates PDZ domain-containing proteins and regulates AMPA receptor transmission. Proc Natl Acad Sci U S A. 2005; 102(42):15006-11. PMC: 1257731. DOI: 10.1073/pnas.0507476102. View

Simensen R, Abidi F, Collins J, Schwartz C, Stevenson R . Cognitive function in Coffin-Lowry syndrome. Clin Genet. 2002; 61(4):299-304. DOI: 10.1034/j.1399-0004.2002.610410.x. View

Stephenson J, Hoffman M, Russell A, Falconer J, Beach R, Tolmie J . The movement disorders of Coffin-Lowry syndrome. Brain Dev. 2005; 27(2):108-13. DOI: 10.1016/j.braindev.2003.11.010. View

Zeniou M, Ding T, Trivier E, Hanauer A . Expression analysis of RSK gene family members: the RSK2 gene, mutated in Coffin-Lowry syndrome, is prominently expressed in brain structures essential for cognitive function and learning. Hum Mol Genet. 2002; 11(23):2929-40. DOI: 10.1093/hmg/11.23.2929. View

Hauge C, Frodin M . RSK and MSK in MAP kinase signalling. J Cell Sci. 2006; 119(Pt 15):3021-3. DOI: 10.1242/jcs.02950. View

Yang X, Matsuda K, Bialek P, Jacquot S, Masuoka H, Schinke T . ATF4 is a substrate of RSK2 and an essential regulator of osteoblast biology; implication for Coffin-Lowry Syndrome. Cell. 2004; 117(3):387-98. DOI: 10.1016/s0092-8674(04)00344-7. View

Strachan R, Sheffler D, Willard B, Kinter M, Kiselar J, Roth B . Ribosomal S6 kinase 2 directly phosphorylates the 5-hydroxytryptamine 2A (5-HT2A) serotonin receptor, thereby modulating 5-HT2A signaling. J Biol Chem. 2008; 284(9):5557-73. PMC: 2645816. DOI: 10.1074/jbc.M805705200. View

Merienne K, Jacquot S, Pannetier S, Zeniou M, Bankier A, Gecz J . A missense mutation in RPS6KA3 (RSK2) responsible for non-specific mental retardation. Nat Genet. 1999; 22(1):13-4. DOI: 10.1038/8719. View

Lowry B, Miller J, Fraser F . A new dominant gene mental retardation syndrome. Association with small stature, tapering fingers, characteristic facies, and possible hydrocephalus. Am J Dis Child. 1971; 121(6):496-500. View

10.

Micheli V, Sestini S, Parri V, Fichera M, Romano C, Ariani F . RSK2 enzymatic assay as a second level diagnostic tool in Coffin-Lowry syndrome. Clin Chim Acta. 2007; 384(1-2):35-40. DOI: 10.1016/j.cca.2007.05.016. View

11.

Martinez-Garay I, Ballesta M, Oltra S, Orellana C, Palomeque A, Molto M . Intronic L1 insertion and F268S, novel mutations in RPS6KA3 (RSK2) causing Coffin-Lowry syndrome. Clin Genet. 2004; 64(6):491-6. DOI: 10.1046/j.1399-0004.2003.00166.x. View

12.

Fischer M, Raabe T, Heisenberg M, Sendtner M . Drosophila RSK negatively regulates bouton number at the neuromuscular junction. Dev Neurobiol. 2009; 69(4):212-20. DOI: 10.1002/dneu.20700. View

13.

Field M, Tarpey P, Boyle J, Edkins S, Goodship J, Luo Y . Mutations in the RSK2(RPS6KA3) gene cause Coffin-Lowry syndrome and nonsyndromic X-linked mental retardation. Clin Genet. 2006; 70(6):509-15. PMC: 2714973. DOI: 10.1111/j.1399-0004.2006.00723.x. View

14.

Temtamy S, Miller J, Hussels-Maumenee I . The Coffin-Lowry syndrome: an inherited faciodigital mental retardation syndrome. J Pediatr. 1975; 86(5):724-31. DOI: 10.1016/s0022-3476(75)80357-x. View

15.

Jacquot S, Merienne K, De Cesare D, Pannetier S, Mandel J, Sassone-Corsi P . Mutation analysis of the RSK2 gene in Coffin-Lowry patients: extensive allelic heterogeneity and a high rate of de novo mutations. Am J Hum Genet. 1998; 63(6):1631-40. PMC: 1377634. DOI: 10.1086/302153. View

16.

De Cesare D, Jacquot S, Hanauer A, Sassone-Corsi P . Rsk-2 activity is necessary for epidermal growth factor-induced phosphorylation of CREB protein and transcription of c-fos gene. Proc Natl Acad Sci U S A. 1998; 95(21):12202-7. PMC: 22809. DOI: 10.1073/pnas.95.21.12202. View

17.

Kang S, Elf S, Dong S, Hitosugi T, Lythgoe K, Guo A . Fibroblast growth factor receptor 3 associates with and tyrosine phosphorylates p90 RSK2, leading to RSK2 activation that mediates hematopoietic transformation. Mol Cell Biol. 2009; 29(8):2105-17. PMC: 2663316. DOI: 10.1128/MCB.00998-08. View

18.

Kesler S, Simensen R, Voeller K, Abidi F, Stevenson R, Schwartz C . Altered neurodevelopment associated with mutations of RSK2: a morphometric MRI study of Coffin-Lowry syndrome. Neurogenetics. 2007; 8(2):143-7. PMC: 3055244. DOI: 10.1007/s10048-007-0080-6. View

19.

Horn D, Delaunoy J, Kunze J . Prenatal diagnosis in Coffin-Lowry syndrome demonstrates germinal mosaicism confirmed by mutation analysis. Prenat Diagn. 2001; 21(10):881-4. View

20.

Jacquot S, Merienne K, Pannetier S, Blumenfeld S, Schinzel A, Hanauer A . Germline mosaicism in Coffin-Lowry syndrome. Eur J Hum Genet. 1999; 6(6):578-82. DOI: 10.1038/sj.ejhg.5200230. View